Bradley Foster & Sargent Inc. CT Reduces Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bradley Foster & Sargent Inc. CT decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 39.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 246,155 shares of the company’s stock after selling 159,032 shares during the quarter. Bradley Foster & Sargent Inc. CT owned approximately 0.05% of GE HealthCare Technologies worth $19,244,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of GEHC. Mesirow Financial Investment Management Inc. raised its stake in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock valued at $383,000 after purchasing an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the fourth quarter valued at $670,000. LMR Partners LLP purchased a new stake in GE HealthCare Technologies during the third quarter valued at $7,387,000. Principal Financial Group Inc. increased its holdings in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after buying an additional 19,010 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at about $1,396,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $92.09 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a 50 day moving average price of $84.85 and a 200 day moving average price of $85.76. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The stock has a market cap of $42.11 billion, a PE ratio of 21.27, a P/E/G ratio of 3.20 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on GEHC shares. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.